Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_assertion type Assertion NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_head.
- NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_assertion description "[Based on our previous results showing that drug-resistant and metastatic cancer cells have high levels of tissue transglutaminase (TG2) expression and that this expression can confer chemoresistance to certain types of cancer cells, we hypothesized that TG2 contributes to constitutive activation of NF-kappaB.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_provenance.
- NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_assertion evidence source_evidence_literature NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_provenance.
- NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_assertion SIO_000772 16951195 NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_provenance.
- NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_assertion wasDerivedFrom befree-20150227 NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_provenance.
- NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_assertion wasGeneratedBy ECO_0000203 NP735056.RAwG_7VauOjg8invJWfc9e_a6pc7aW5rHmoF75qlO2AbY130_provenance.